These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1639130

  • 1. Transformation and characterization of mutant human fibroblasts defective in peroxisome assembly.
    Okamoto H, Suzuki Y, Shimozawa N, Yajima S, Masuno M, Orii T.
    Exp Cell Res; 1992 Aug; 201(2):307-12. PubMed ID: 1639130
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical biochemical and genetic aspects of peroxisome-deficient disorders].
    Suzuki Y.
    No To Hattatsu; 1992 Mar; 24(2):194-7. PubMed ID: 1373633
    [Abstract] [Full Text] [Related]

  • 5. Genetic relationship between the Zellweger syndrome and other peroxisomal disorders characterized by an impairment in the assembly of peroxisomes.
    Tager JM, Brul S, Wiemer EA, Strijland A, Van Driel R, Schutgens RB, Van den Bosch H, Wanders RJ, Westerveld A.
    Prog Clin Biol Res; 1990 Mar; 321():545-58. PubMed ID: 2183242
    [Abstract] [Full Text] [Related]

  • 6. Correction by gene expression of biochemical abnormalities in fibroblasts from Zellweger patients.
    Shimozawa N, Suzuki Y, Tomatsu S, Tsukamoto T, Osumi T, Fujiki Y, Kamijo K, Hashimoto T, Kondo N, Orii T.
    Pediatr Res; 1996 May; 39(5):812-5. PubMed ID: 8726233
    [Abstract] [Full Text] [Related]

  • 7. Immunochemical and biochemical studies of fatty acid oxidation in fibroblasts of Zellweger and X-linked adrenoleukodystrophy patients.
    Reubsaet FA, Veerkamp JH, Brückwilder ML, Trijbels JM, Hashimoto T, Monnens LA.
    Biochim Biophys Acta; 1991 Jun 03; 1083(3):305-9. PubMed ID: 2049396
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis.
    Brul S, Westerveld A, Strijland A, Wanders RJ, Schram AW, Heymans HS, Schutgens RB, van den Bosch H, Tager JM.
    J Clin Invest; 1988 Jun 03; 81(6):1710-5. PubMed ID: 2454948
    [Abstract] [Full Text] [Related]

  • 10. Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I.
    Tamura S, Okumoto K, Toyama R, Shimozawa N, Tsukamoto T, Suzuki Y, Osumi T, Kondo N, Fujiki Y.
    Proc Natl Acad Sci U S A; 1998 Apr 14; 95(8):4350-5. PubMed ID: 9539740
    [Abstract] [Full Text] [Related]

  • 11. Biochemical features of a patient with Zellweger-like syndrome with normal PTS-1 and PTS-2 peroxisomal protein import systems: a new peroxisomal disease.
    Singh I, Voigt RG, Sheikh FG, Kremser K, Brown FR.
    Biochem Mol Med; 1997 Aug 14; 61(2):198-207. PubMed ID: 9259985
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome.
    Shimozawa N, Tsukamoto T, Suzuki Y, Orii T, Fujiki Y.
    J Clin Invest; 1992 Nov 14; 90(5):1864-70. PubMed ID: 1430210
    [Abstract] [Full Text] [Related]

  • 14. Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency.
    Abe Y, Honsho M, Nakanishi H, Taguchi R, Fujiki Y.
    Biochim Biophys Acta; 2014 Apr 04; 1841(4):610-9. PubMed ID: 24418004
    [Abstract] [Full Text] [Related]

  • 15. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients.
    Roscher AA, Hoefler S, Hoefler G, Paschke E, Paltauf F, Moser A, Moser H.
    Pediatr Res; 1989 Jul 04; 26(1):67-72. PubMed ID: 2475849
    [Abstract] [Full Text] [Related]

  • 16. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ, van Roermund CW, van Wijland MJ, Heikoop J, Schutgens RB, Schram AW, Tager JM, van den Bosch H, Poll-Thé BT, Saudubray JM.
    Clin Chim Acta; 1987 Jul 15; 166(2-3):255-63. PubMed ID: 2441904
    [Abstract] [Full Text] [Related]

  • 17. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups.
    Moser AB, Rasmussen M, Naidu S, Watkins PA, McGuinness M, Hajra AK, Chen G, Raymond G, Liu A, Gordon D.
    J Pediatr; 1995 Jul 15; 127(1):13-22. PubMed ID: 7541833
    [Abstract] [Full Text] [Related]

  • 18. Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy.
    Chen WW, Watkins PA, Osumi T, Hashimoto T, Moser HW.
    Proc Natl Acad Sci U S A; 1987 Mar 15; 84(5):1425-8. PubMed ID: 3469675
    [Abstract] [Full Text] [Related]

  • 19. Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D.
    Honsho M, Tamura S, Shimozawa N, Suzuki Y, Kondo N, Fujiki Y.
    Am J Hum Genet; 1998 Dec 15; 63(6):1622-30. PubMed ID: 9837814
    [Abstract] [Full Text] [Related]

  • 20. Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression.
    Braiterman LT, Watkins PA, Moser AB, Smith KD.
    Mol Genet Metab; 1999 Feb 15; 66(2):91-9. PubMed ID: 10068511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.